A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

Trial Identifier: D3250R00062
Sponsor: AstraZeneca
NCTID:: NCT04808518
Start Date: December 2019
Primary Completion Date: November 2023
Study Completion Date: November 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aki-gun Fucyu, Japan
Japan Asahikawa, Japan
Japan Bunkyo, Japan
Japan Fukuoka, Japan
Japan Hamamatsu, Japan
Japan Hiroshima, Japan
Japan Ikoma, Japan
Japan Itabashi, Japan
Japan Kobe, Japan
Japan Kumagaya, Japan
Japan Maebashi, Japan
Japan Meguro, Japan
Japan Nagoya, Japan
Japan Nangoku, Japan
Japan Niigata, Japan
Japan Okayama, Japan
Japan Osaka, Japan
Japan Osakasayama, Japan
Japan Otsu, Japan
Japan Sagamihara, Japan
Japan Shinagawa, Japan
Japan Shinjuku, Japan
Japan Shizuoka, Japan
Japan Toyoake, Japan
Japan Tsukubo-gun Hayashima, Japan
Japan Yamagata, Japan
Japan Yokohama, Japan
Japan Yonago, Japan